medtronic cardiovascular organic growth in fiscal 2027
Above 8%
medtronic cardiovascular organic growth in fiscal 2027. Best Yes near 85¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 85¢ · Best No: 24¢ · 1 platform
- Kalshi: Yes 85¢ / No 24¢
TRADING OPEN
Above 8%
Volume
$0
$0 24h
Platforms
1
Cross-platform pricing
Resolution
Resolves Jun 2, 2027
~261 days left
Category
Economics
Yes
85¢
Kalshi
No
24¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platform
Price History
Loading…
About This Market
If Medtronic plc reports Above 8% cardiovascular organic revenue growth in fiscal 2027, then the market resolves to Yes.
Market Details
ResolutionResolves Jun 2, 2027
Time Left261 days
Status● Active
CategoryEconomics
Yes
85¢
Kalshi
Payout 1.2x
No
24¢
Kalshi
Payout 4.2x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In